PPD DEVELOPMENT LP - ADVANCED RESEARCH AND DEVELOPMENT ACTIVITIES FOR NOVEL IMMUNOGENICITY ASSAYS AND SAMPLE COLLECTION TECHNOLOGIES AS PART OF BARDA?S CONTINUING SUPPORT FOR COVID-19 VACCINE DEVELOPMENT, ASSESSING IMPACT OF VARIANTS ON VACCINE IMMUNOGENICITY, AND ANALYZ
Key Details
Description
ADVANCED RESEARCH AND DEVELOPMENT ACTIVITIES FOR NOVEL IMMUNOGENICITY ASSAYS AND SAMPLE COLLECTION TECHNOLOGIES AS PART OF BARDA?S CONTINUING SUPPORT FOR COVID-19 VACCINE DEVELOPMENT, ASSESSING IMPACT OF VARIANTS ON VACCINE IMMUNOGENICITY, AND ANALYZ
Context & Analysis
On Sep 29, 2023, Department of Health and Human Services obligated $126,485,055 to PPD DEVELOPMENT LP for advanced research and development activities for novel immunogenicity assays and sample collection technologies as part of barda?s continuing support for covid-19 vaccine development, assessing impact…. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY). Competition extent: not competed with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in WILMINGTON, NC. The contract is scheduled through Sep 28, 2029. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.
Contractor Information
Related Federal Investment
Similar Awards
Stay Updated
Get notified about new opportunities matching your interests.